Relationships among red cell distribution width, anemia, and interleukin-6 in adult congenital heart disease

Circulation Journal

Volumn 79, Issue 5, 2015, Pages 1100-1106

  Miyamoto, Kenji ^a   Inai, Kei ^a   Takeuchi, Daiji ^a   Shinohara, Tokuko ^a   Nakanishi, Toshio ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Congenital heart disease; Interleukin 6; Microcytic anemia; Red cell distribution width

Indexed keywords

HEMOGLOBIN; INTERLEUKIN 6; IL6 PROTEIN, HUMAN;

ADULT; ANEMIA; ARTICLE; CARDIOVASCULAR MORTALITY; CELLULAR PARAMETERS; CHEMILUMINESCENCE IMMUNOASSAY; CLINICAL ASSESSMENT; CONGENITAL HEART DISEASE; CYANOSIS; FEMALE; FOLLOW UP; HEART DEATH; HEMATOCRIT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEAN CORPUSCULAR VOLUME; MORTALITY; OXYGEN SATURATION; PREVALENCE; RED CELL DISTRIBUTION WIDTH; RETROSPECTIVE STUDY; SURVIVAL; BLOOD; CLINICAL TRIAL; COMPLICATION; CONGENITAL HEART MALFORMATION;

ADULT; ANEMIA; ERYTHROCYTE INDICES; FEMALE; FOLLOW-UP STUDIES; HEART DEFECTS, CONGENITAL; HUMANS; INTERLEUKIN-6; MALE; RETROSPECTIVE STUDIES;

EID: 84928468646     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-14-1296     Document Type: Article

References (31)

1. Bessman JD, Gilmer PR Jr, Gardner FH. Improved classification of anemias by MCV and RDW. Am J Clin Pathol 1983; 80: 322-326.
2. Aung N, Ling HZ, Cheng AS, Aggarwal S, Flint J, Mendonca M, et al. Expansion of the red cell distribution width and evolving iron deficiency as predictors of poor outcome in chronic heart failure. Int J Cardiol 2013; 168: 1997-2002.
3. Olcay L, Ozer S, Gürgey A, Saraçlar M, Ozme S, Bilgiç A, et al. Parameters of iron deficiency in children with cyanotic congenital heart disease. Pediatr Cardiol 1996; 17: 150-154.
4. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med 2005; 352: 1011-1023.
5. Patel KV, Semba RD, Ferrucci L, Newman AB, Fried LP, Wallace RB, et al. Red cell distribution width and mortality in older adults: A meta-analysis. J Gerontol A Biol Sci Med Sci 2010; 65: 258-265.
6. Hunziker S, Stevens J, Howell MD. Red cell distribution width and mortality in newly hospitalized patients. Am J Med 2012; 125: 283-291.
7. Felker GM, Allen LA, Pocock SJ, Shaw LK, McMurray JJ, Pfeffer MA, et al. Red cell distribution width as a novel prognostic marker in heart failure: Data from the CHARM Program and the Duke Databank. J Am Coll Cardiol 2007; 50: 40-47.
8. Mitchell RM, Robinson TJ. Monitoring dietary compliance in coeliac disease using red cell distribution width. Int J Clin Pract 2002; 56: 249-250.
9. Martínez-Quintana E, Rodríguez-González F. Iron deficiency anemia detection from hematology parameters in adult congenital heart disease patients. Congenit Heart Dis 2013; 8: 117-123.
10. Broberg CS, Jayaweera AR, Diller GP, Prasad SK, Thein SL, Bax BE, et al. Seeking optimal relation between oxygen saturation and hemoglobin concentration in adults with cyanosis from congenital heart disease. Am J Cardiol 2011; 107: 595-599.
11. Ohuchi H, Diller GP. Biomarkers in adult congenital heart disease heart failure. Heart Fail Clin 2014; 10: 43-56.
12. Oh J, Kang SM, Won H, Hong N, Kim SY, Park S, et al. Prognostic value of change in red cell distribution width 1 month after discharge in acute decompensated heart failure patients. Circ J 2012; 76: 109-116.
13. Tsuboi S, Miyauchi K, Kasai T, Ogita M, Dohi T, Miyazaki T, et al. Impact of red blood cell distribution width on long-term mortality in diabetic patients after percutaneous coronary intervention. Circ J 2013; 77: 456-461.
14. Makhoul BF, Khourieh A, Kaplan M, Bahouth F, Aronson D, Azzam ZS. Relation between changes in red cell distribution width and clinical outcomes in acute decompensated heart failure. Int J Cardiol 2013; 167: 1412-1416.
15. Förhécz Z, Gombos T, Borgulya G, Pozsonyi Z, Prohászka Z, Jánoskuti L. Red cell distribution width in heart failure: Prediction of clinical events and relationship with markers of ineffective erythropoiesis, inflammation, renal function, and nutritional state. Am Heart J 2009; 158: 659-666.
16. Borné Y, Smith JG, Melander O, Hedblad B, Engström G. Red cell distribution width and risk for first hospitalization due to heart failure: A population-based cohort study. Eur J Heart Fail 2011; 13: 1355-1361.
17. Al-Najjar Y, Goode KM, Zhang J, Cleland JG, Clark AL. Red cell distribution width: An inexpensive and powerful prognostic marker in heart failure. Eur J Heart Fail 2009; 11: 1155-1162.
18. Núñez J, Núñez E, Rizopoulos D, Miñana G, Bodí V, Bondanza L, et al. Red blood cell distribution width is longitudinally associated with mortality and anemia in heart failure patients. Circ J 2014; 78: 410-418.
19. Pascual-Figal DA, Bonaque JC, Manzano-Fernández S, Fernández A, Garrido IP, Pastor-Perez F, et al. Red blood cell distribution width predicts new-onset anemia in heart failure patients. Int J Cardiol 2012; 160: 196-200.
20. Warwick R, Mediratta N, Shaw M, McShane J, Pullan M, Chalmers J, et al. Red cell distribution width and coronary artery bypass surgery. Eur J Cardiothorac Surg 2013; 43: 1165-1169.
21. Massin MM. Relation between red cell distribution width and clinical outcome after surgery for congenital heart disease in children. Pediatr Cardiol 2012; 33: 1021-1025.
22. Aung N, Dworakowski R, Byrne J, Alcock E, Deshpande R, Rajagopal K, et al. Progressive rise in red cell distribution width is associated with poor outcome after transcatheter aortic valve implantation. Heart 2013; 99: 1261-1266.
23. Kaemmerer H, Fratz S, Braun SL, Koelling K, Eicken A, Brodherr- Heberlein S, et al. Erythrocyte indexes, iron metabolism, and hyperhomocysteinemia in adults with cyanotic congenital cardiac disease. Am J Cardiol 2004; 94: 825-828.
24. Dopsaj V, Mikovic-Golubovic G, Martinovic J, Kalimanovska- Ostric D. Evaluation of derived Coulter red blood cell parameters for the assessment of iron deficiency in adults with congenital heart disease. Int J Lab Hematol 2012; 34: 461-472.
25. Broberg CS, Bax BE, Okonko DO, Rampling MW, Bayne S, Harries C, et al. Blood viscosity and its relationship to iron deficiency, symptoms, and exercise capacity in adults with cyanotic congenital heart disease. J Am Coll Cardiol 2006; 48: 356-365.
26. Tomkiewicz-Pajak L, Plazak W, Kolcz J, Pajak J, Kopec G, Dluzniewska N, et al. Iron deficiency and hematological changes in adult patients after Fontan operation. J Cardiol 2014; 64: 384-389.
27. Onur CB, Sipahi T, Tavil B, Karademir S, Yoney A. Diagnosing iron deficiency in cyanotic heart disease. Indian J Pediatr 2003; 70: 29-31.
28. Allen LA, Felker GM, Mehra MR, Chiong JR, Dunlap SH, Ghali JK, et al. Validation and potential mechanisms of red cell distribution width as a prognostic marker in heart failure. J Card Fail 2010; 16: 230-238.
29. Bolger AP, Sharma R, Li W, Leenarts M, Kalra PR, Kemp M, et al. Neurohormonal activation and the chronic heart failure syndrome in adults with congenital heart disease. Circulation 2002; 106: 92-99.
30. Bolger AP, Coats AJ, Gatzoulis MA. Congenital heart disease: The original heart failure syndrome. Eur Heart J 2003; 24: 970-976.
31. Braunwald E. Biomarkers in heart failure. N Engl J Med 2008; 358: 2148-2159.